Zivo Bioscience, Inc. Warrants
ZIVOW
ZIVOW was delisted on the 24th of November, 2023.
6 hedge funds and large institutions have $86.8K invested in Zivo Bioscience, Inc. Warrants in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
23% less capital invested
Capital invested by funds: $113K → $86.8K (-$26.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.86K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$3.26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Warberg Asset Management
Winnetka,
Illinois
| $45.2K | -$3.26K | -6,488 | -6% |
|
|
AC
2
Ayrton Capital
Westport,
Connecticut
| $21.9K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $7.97K | +$3.86K | +7,697 | +76% |
|
|
CH
4
CVI Holdings
Wilmington,
Delaware
| $7.22K | – | – | – |
|
|
VCA
5
Verdence Capital Advisors
Hunt Valley,
Maryland
| $4.48K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $13 | +$15 | +30 | New |
|
ZIVOW Hedge Fund Activity: Q3 2023 in Review
6 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q3 2023, worth a combined $86.8K — down 23% from $113K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ZIVOW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $3.86K. The largest seller was Warberg Asset Management, cutting an estimated $3.26K.
- 6 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $86.8K of Zivo Bioscience, Inc. Warrants stock for Q3 2023, down 23% quarter-over-quarter.
- 1 fund opened new Zivo Bioscience, Inc. Warrants positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Zivo Bioscience, Inc. Warrants buyer in Q3 2023 was Citadel Advisors, an estimated $3.86K added.
- The largest Zivo Bioscience, Inc. Warrants seller in Q3 2023 was Warberg Asset Management, an estimated $3.26K sold.
Based on aggregated 13F filings for Q3 2023.